Pablo Zubiaur

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 48

Top Venues

Pharmaceutics

Journal of personalized medicine

Clinical and translational science

Clinical pharmacology and therapeutics

Hospital Universitario de la Princesa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario de la Princesa Feb 01 2018

Spain

Researcher :: Farmacología

Publications

Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Katherine M Robinson, Seenae Eum, Zeruesenay Desta, Rachel Fynvola Tyndale, Andrea Gaedigk, Richard C Crist, Cyrine E Haidar, Alan L Myers, Caroline Flora Samer, Andrew Alexander Somogyi, Pablo Zubiaur, Otito F Iwuchukwu, Michelle Whirl-Carrillo, Teri E Klein, Kelly E Caudle, Roseann S Donnelly, Evan D Kharasch
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical pharmacology and therapeutics (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Pablo Zubiaur, Cristina Rodríguez-Antona, Erin C Boone, Ann K Daly, Evangelia-Eirini Tsermpini, Lubna Q Khasawneh, Katrin Sangkuhl, Jorge Duconge, Mariana Rodrigues Botton, Jessica Savieo, Charity Nofziger, Michelle Whirl-Carrillo, Teri E Klein, Andrea Gaedigk
PharmVar GeneFocus: CYP4F2. Clinical pharmacology and therapeutics (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio José Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona Francés, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander Vaquero, Pablo Zubiaur
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 25 (7) (2024)
Pablo Zubiaur, James Steven Leeder, Francisco Abad-Santos, Andrea Gaedigk
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?" Clinical pharmacology and therapeutics (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Marcos Navares-Gómez, Houwaida Abbes, Gonzalo Villapalos-García, Alejandro de Miguel, Eva González-Iglesias, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Samuel Martín-Vilchez, Sergio Luquero-Bueno, Manuel Román, Francisco Abad-Santos
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International journal of molecular sciences 24 (20) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Pablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone, Bhagwat Prasad, Jean Dinh, Wendy Y Wang, Santiago Zugbi, Andrea Rodríguez-Lopez, Eva González-Iglesias, James Steven Leeder, Francisco Abad-Santos, Andrea Gaedigk
Impact of CYP2C:TG haplotype on CYP2C19 substrates clearance in vivo, protein content and in vitro activity. Clinical pharmacology and therapeutics (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Gonzalo Villapalos-García, Pablo Zubiaur, Cristina Marián-Revilla, Paula Soria-Chacartegui, Marcos Navares-Gómez, Gina P Mejía-Abril, Andrea Rodríguez-Lopez, Eva González-Iglesias, Samuel Martín-Vílchez, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. Journal of personalized medicine 13 (11) (2023)
Sarahí Valdez-Acosta, Pablo Zubiaur, Miguel Angel Casado, Jesús Novalbos, Ana Casajús, Diana Campodónico, Itziar Oyagüez, Francisco Abad-Santos
Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases. Journal of personalized medicine 13 (8) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Jaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, Inés Cancio, José Ramón Arribas, Carmen Suarez Fernández, Jesús Mingorance, Julio García-Rodríguez, José Ramón Villagrasa Ferrer, Antonio J Carcas, Jesús Frías, Francisco Abad-Santos, Alberto M Borobia, Elena Ramírez García, null On Behalf Of The Covid Hulp Working Group And Other Collaborators From Hospital Universitario de la Princesa
A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals (Basel, Switzerland) 15 (1) (2022)
Álvaro Pinto-Merino, Jorge Labrador-Gomez, Pablo Zubiaur, Raquel Alcaraz, Maria José Herrero, Pau Montesinos, Francisco Abad-Santos, Miriam Saiz-Rodriguez
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics 14 (3) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui, Ana Casajús, Gonzalo Villapalos-García, Marcos Navares-Gómez, Antía Gómez-Fernández, Raúl Parra-Garcés, Gina P Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 15 (11) (2022)
Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, Lucio García-Fraile Fraile, Paula Fernández-Campos, Paula Soria-Chacartegui, Sara Fernández de Córdoba-Oñate, Pablo Delgado-Wicke, Elena Fernández-Ruiz, Isidoro González-Alvaro, Jesús Sanz, Francisco Abad-Santos, Ignacio De Los Santos
Transmembrane protease serine 2 ( TMPRSS2 ) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life science alliance 5 (10) (2022)
Yi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, Bianca Posocco, María Angeles Pena Pardo, Alberto M Borobia, Sara Gagno, Francisco Abad-Santos, Georg Hempel
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg. Cancer chemotherapy and pharmacology 90 (2) (2022)
Pablo Zubiaur, David Nicolás Prósper-Cuesta, Jesús Novalbos, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Francisco Abad-Santos
Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review. Journal of personalized medicine 12 (2) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations. Pharmacogenomics 23 (18) (2022)
María C Ovejero-Benito, Dolores Ochoa, Teresa Enrique-Benedito, Miriam Del Peso-Casado, Pablo Zubiaur, Marcos Navares, Manuel Román, Francisco Abad-Santos
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects. Journal of personalized medicine 12 (5) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina P Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics 14 (10) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, Lucio García-Fraile Fraile, Paula Fernández-Campos, Paula Soria-Chacartegui, Sara Fernández de Córdoba-Oñate, Pablo Delgado-Wicke, Elena Fernández-Ruiz, Isidoro González-Alvaro, Jesús Sanz, Francisco Abad-Santos, Ignacio De Los Santos
Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity. Life science alliance 5 (10) (2022)
Pablo Zubiaur, Francisco Abad-Santos
Association Studies in Clinical Pharmacogenetics. Pharmaceutics 15 (1) (2022)
Pablo Zubiaur, Andrea Gaedigk
CYP2C18: the orphan in the CYP2C family. Pharmacogenomics 23 (17) (2022)
Pablo Zubiaur, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Dolores Ochoa, Francisco Abad-Santos
PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics. Journal of clinical medicine 10 (17) (2021)
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández, Marcos Navares-Gómez, Gina P Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study. Pharmaceutics 13 (12) (2021)
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina P Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 13 (10) (2021)
Pablo Zubiaur, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Juan J Gordillo-Perdomo, Francisco Abad-Santos
The pharmacogenetics of treatment with olanzapine. Pharmacogenomics 22 (14) (2021)
Pablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, Marcos Navares-Gómez, Gina Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability. Journal of personalized medicine 11 (3) (2021)
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Alberto M Borobia, Dora Koller, Irene García García, Marcos Navares-Gómez, Georg Hempel, Francisco Abad-Santos
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 60 (2) (2021)
Diana Grajales, Patricia Vázquez, Mónica Ruíz-Rosario, Eva Tudurí, Mercedes Mirasierra, Vítor Ferreira, Ana Belén Hitos, Dora Koller, Pablo Zubiaur, Juan C Cigudosa, Francisco Abad-Santos, Mario Vallejo, Iván Quesada, Boaz Tirosh, Gil Leibowitz, Ángela M Valverde
The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia 65 (3) (2021)
Dora Koller, Susana Almenara, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 36 (1) (2020)
Pablo Zubiaur, Dora Koller, Miriam Saiz-Rodriguez, Marcos Navares-Gómez, Francisco Abad-Santos
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clinical and translational science 13 (6) (2020)

Pablo Zubiaur.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pablo Zubiaur